Patricia A Olofsen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Advanced Non Small Cell Lung Cancer

Vascular Endothelial Growth Factor

Immune Response

Top Venues

Cancer immunology, immunotherapy : CII

British journal of haematology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Chilam Chan, J H Marco Jansen, Ilona S T Hendriks, Ida C van der Peet, Meggy E L Verdonschot, Elsemieke M Passchier, Maria Tsioumpekou, Maaike Nederend, Sharon A Klomp, Matthias Peipp, Thomas Valerius, Jeanette H W Leusen, Patricia A Olofsen
Enhancing neutrophil cytotoxicity of a panel of clinical EGFR antibodies by Fc engineering to IgA3.0. Molecular cancer therapeutics (2024)
Marjolein C Stip, J H Marco Jansen, Maaike Nederend, Maria Tsioumpekou, Mitchell Evers, Patricia A Olofsen, Friederike Meyer-Wentrup, Jeanette H W Leusen
Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains. Cancer immunology, immunotherapy : CII (2023)
Maria Tsioumpekou, Daniëlle Krijgsman, Jeanette H W Leusen, Patricia A Olofsen
The Role of Cytokines in Neutrophil Development, Tissue Homing, Function and Plasticity in Health and Disease. Cells 12 (15) (2023)
Patricia A Olofsen, Dennis A Bosch, Hans W J de Looper, Paulina M H van Strien, Remco M Hoogenboezem, Onno Roovers, Vincent H J van der Velden, Eric M J Bindels, Emma M De Pater, Ivo P Touw
Truncated CSF3 receptors induce pro-inflammatory responses in severe congenital neutropenia. British journal of haematology (2022)
Patricia A Olofsen, Marjolein C Stip, J H Marco Jansen, Chilam Chan, Maaike Nederend, Ralph G Tieland, Maria Tsioumpekou, Jeanette H W Leusen
Effective, Long-Term, Neutrophil Depletion Using a Murinized Anti-Ly-6G 1A8 Antibody. Cells 11 (21) (2022)